ロード中...
Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury
BACKGROUND AND PURPOSE: Endothelin (ET) receptor antagonism reduces neointimal lesion formation in animal models. This investigation addressed the hypothesis that the selective ET(A) receptor antagonist sitaxentan would be more effective than mixed ET(A)(/)(B) receptor antagonism at inhibiting neoin...
保存先:
| 出版年: | Br J Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BlackWell Publishing Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4439878/ https://ncbi.nlm.nih.gov/pubmed/25598351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13086 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|